583 results on '"Ruocco, Vincenzo"'
Search Results
102. Erratum to “Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies” [Clin Dermatol 2010; 28:337-343]
103. Drug-triggered pemphigus in a predisposed woman
104. Isotopic response
105. Viruses and Pemphigus: An Intriguing Never-Ending Story
106. A Possible Mechanism for Phenol‐Induced Pemphigus
107. Monolesional Kaposi Sarcoma at the Site of Slow Healing Herpes Zoster in an HIV+ Patient
108. Segmental immune disorders related to herpes zoster
109. RETRACTED: Bullous pemphigoid: Associations and management guidelines
110. Contact dermatitis: Facts and controversies
111. Pemphigus: Etiology, pathogenesis, and inducing or triggering factors: Facts and controversies
112. Pemphigus: Associations and management guidelines: Facts and controversies
113. Phacomatosis pigmento-pigmentaria: Should we add a new type of phacomatosis? Fact and controversies
114. Bullous pemphigoid: Etiology, pathogenesis, and inducing factors: Facts and controversies
115. Patch testing: Facts and controversies
116. Kaposi’s sarcoma: Etiology and pathogenesis, inducing factors, causal associations, and treatments: Facts and controversies
117. Non-melanoma skin cancer: an overindulged circumlocution articulating keratinocytic cancer
118. Granulomatous skin lesions on an amputated limb: a typical case of an immunocompromised district
119. Structure and function of the epidermis related to barrier properties
120. Abnormal epidermal barrier in the pathogenesis of psoriasis
121. Opportunistic localization of skin lesions on vulnerable areas
122. Diagnostic procedures in dermatology
123. Wolf's isotopic response
124. Kaposi’s Sarcoma Restricted to an Immunocompromised District
125. MDM2 and CDKN1A gene polymorphisms and risk of Kaposi’s sarcoma in African and Caucasian patients
126. Human herpesvirus type 8 variants in Kaposi's sarcoma before and after AIDS era
127. Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies
128. TP53 Codon 72 Polymorphism in Classic, Endemic and Epidemic Kaposi’s Sarcoma in African and Caucasian Patients
129. Vesicular and Bullous Disorders: Pemphigus
130. Drug-induced pemphigus in a predisposed girl⋆
131. Life-threatening bullous dermatoses: Pemphigus vulgaris
132. Imiquimod contact pemphigus: a comment
133. Treatment of toxic epidermal necrolysis syndrome with “disease-modifying” drugs: The controversy goes on
134. Diagnosis and Treatment of Cutaneous Melanoma: A Practical Guide
135. Parasitic skin infestations II, scabies, pediculosis, spider bites: unapproved treatments
136. Adverse drug reactions and graft-versus-host reaction: unapproved treatments
137. Anti-TNF therapies—the hope of tomorrow
138. Clinical simulators of melanoma
139. Commentary: dermoscopy
140. Impact of dermoscopy on the clinical management of pigmented skin lesions
141. Cytokine Pattern in Blister Fluid and Sera of Patients with Pemphigus
142. Sunscreens
143. Precautions and Suggestions for Pemphigus Patients
144. Bullous diseases: unapproved treatments or indications
145. Antimalarials: unapproved uses or indications
146. Lesion topography in two cases of nifedipine-related pemphigus
147. Dermatological manifestations of alcoholic cirrhosis
148. Alcohol intake and psoriasis11The opinions expressed herein are solely those of the writers and do not necessarily reflect the opinions of the institutions with which the writers have been associated.
149. Thein vitroeffect of hydroxychloroquine on skin morphology in psoriasis
150. Antifungal sponsored supplements*
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.